Questionable Relevance of γδ T Lymphocytes in Renal Cell Carcinoma
- 1 March 2008
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 180 (5), 3578-3584
- https://doi.org/10.4049/jimmunol.180.5.3578
Abstract
Adoptive γδ T cell immunotherapy has moved briskly into clinical trials prompted by several small studies suggesting abundant accumulation of γδ T cells within renal cell carcinoma (RCC). In this study, we re-examined levels of γδ T cells within RCC tumors and correlated levels of these cells with pathologic features and outcome associated with this form of cancer. Tissues from 248 consecutive clear cell RCC tumors obtained from 2000 to 2003 were stained and quantified for total CD3+ and γδ T cells per mm2. Wilcoxon rank sum and Kruskal-Wallis tests were used to evaluate associations between T cell amounts and prognostic factors (age, gender, tumor size, stage, grade, tumor necrosis). Cox models were used to assess associations with RCC-specific death. Median numbers of total CD3+ and γδ T cells were 281/mm2 (interquartile range (IQR): 149–536) and 2.6/mm2 (IQR: 1.3–4.6), respectively. The median percentage of CD3+ T cells that were γδ T cells was 1.0% (IQR: 0.4–1.9). This low percentage of intratumoral γδ T cells was diluted even further with rising CD3+ T cell infiltration. Percentages of γδ T cells were not associated with even one single clinicopathologic feature examined. Median follow-up for this study was 3.1 years (48 patients died of RCC) and Cox analysis failed to demonstrate that γδ T cells (hazard ratio = 1.02, p = 0.25) were predictive of RCC-specific death. γδ T cells are rare and not recruited nor expanded within RCC tumors. Percentages of γδ T cells fail to correlate with any prognostic features of RCC nor specific death. As such, the role of γδ T cells in RCC immunobiology remains questionable.Keywords
This publication has 26 references indexed in Scilit:
- Immunoregulation in the tissues by γδ T cellsNature Reviews Immunology, 2003
- Comparison of Standardized and Nonstandardized Nuclear Grade of Renal Cell Carcinoma to Predict Outcome Among 2,042 PatientsAmerican Journal of Clinical Pathology, 2002
- γδ T cells: functional plasticity and heterogeneityNature Reviews Immunology, 2002
- Activated gamma/delta T lymphocytes infiltrating renal cell carcinomaImmunology Letters, 1996
- The statistical analysis of kappa statistics in multiple samplesJournal of Clinical Epidemiology, 1996
- TCRgammadelta Cells: A Specialized T-Cell Subset in the Immune SystemAnnual Review of Cell and Developmental Biology, 1995
- Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2Published by American Medical Association (AMA) ,1994
- Distinct antigen receptor repertoires of two classes of murine epithelium-associated T cellsNature, 1989
- Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody.The Journal of Experimental Medicine, 1988
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985